Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2013, Article ID 258028, 2 pages
http://dx.doi.org/10.1155/2013/258028
Case Report

Daunorubicin, Cytarabine, and Cladribine Regimen Plus Radiotherapy and Donor Lymphocyte Infusion for Extramedullary Relapse of Acute Myeloid Leukemia after Hematopoietic Stem Cell Transplantation

1Hematology Unit and Bone Marrow Transplantation Center, “R. Binaghi” Hospital, Via Is Guadazzonis 3, 09126 Cagliari, Italy
2Department of Medical Sciences, University of Cagliari, 09100 Cagliari, Italy

Received 3 July 2013; Accepted 29 July 2013

Academic Editors: D. J. Allsup and K. Kawauchi

Copyright © 2013 Marco Sanna et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. H. Swerdlow, E. Campo, N. L. Harris et al., Eds., WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, IARC Press, Lyon, France, 2008.
  2. H. Döhner, E. H. Estey, S. Amadori et al., “Diagnosis and management of acute myeloid leukemia in adults: Recommendations from an international expert panel, on behalf of the European LeukemiaNet,” Blood, vol. 115, no. 3, pp. 453–474, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. R. L. Bakst, M. S. Tallman, D. Douer, and J. Yahalom, “How I treat extramedullary acute myeloid leukemia,” Blood, vol. 118, no. 14, pp. 3785–3793, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. J. H. Cho-Vega, L. J. Medeiros, V. G. Prieto, and F. Vega, “Leukemia cutis,” American Journal of Clinical Pathology, vol. 129, no. 1, pp. 130–142, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Holowiecki, S. Grosicki, S. Giebel et al., “Cladribine, but not fludarabine, added to daunorubicin and cytarabine during induction prolongs survival of patients with acute myeloid leukemia: a multicenter, randomized phase III study,” Journal of Clinical Oncology, vol. 30, pp. 2441–2448, 2012. View at Google Scholar
  6. A. Wierzbowska, T. Robak, A. Pluta et al., “Cladribine combined with high doses of arabinoside cytosine, mitoxantrone, and G-CSF (CLAG-M) is a highly effective salvage regimen in patients with refractory and relapsed acute myeloid leukemia of the poor risk: A final report of the Polish Adult Leukemia Group,” European Journal of Haematology, vol. 80, no. 2, pp. 115–126, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Inaba, C. F. Stewart, K. R. Crews et al., “Combination of cladribine plus topotecan for recurrent or refractory pediatric acute myeloid leukemia,” Cancer, vol. 116, no. 1, pp. 98–105, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Genini, S. Adachi, Q. Chao et al., “Deoxyadenosine analogs induce programmed cell death in chronic lymphocytic leukemia cells by damaging the DNA and by directly affecting the mitochondria,” Blood, vol. 96, no. 10, pp. 3537–3543, 2000. View at Google Scholar · View at Scopus